Press Release

5001 Spring Valley Road
Suite 500W
Dallas, Texas, U.S.A. 75244
+1 (877) 868-7042

Vivione Biosciences Inc. Announces Warrant Extension

 

DALLAS, Texas – Vivione Biosciences Inc. (“Vivione” or the “Company”) (TSXV:VBI), is pleased to announce that the TSX Venture Exchange (the “Exchange”) has approved the extension of the expiry date of 12,000,000 common share purchase warrants (the “Warrants”) issued to subscribers as part of the Company’s prospectus financing which closed on April 19, 2013. The expiry dates of the Warrants have been extended for a period of one year from October 19, 2014 to October 14, 2015. All other terms of the Warrants remain the same. The Company will deliver a Notice of Amendment reflecting the amended expiry date to the registered holders of the Warrants.

About Vivione

Vivione is a TSX Venture Exchange listed biosciences company focused on the commercialization of its proprietary RAPID-B system; an integrated system of hardware, software and chemical reagents that quickly and accurately identify, quantify and qualify bacteria and other pathogens in key food & water safety, clinical, industrial and oil & gas environments. For more information, visit www.VivioneBiosciences.com.

Cautionary Statements

This news release contains "forward-looking statements" within the meaning of applicable securities laws. Although Vivione believes that the expectations reflected in its forward-looking statements are reasonable, such statements have been based on factors and assumptions concerning future events that may prove to be inaccurate. These factors and assumptions are based upon currently available information to Vivione. Such statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. This news release contains forward-looking information relating to the commercialization and the development of the RAPID-B system, Vivione’s business and growth strategy, the success of Vivione’s product offerings in the oil and gas sector and the ability of the RAPID-B system to generate revenue. Readers are cautioned to not place undue reliance on forward-looking statements. The statements in this news release are made as of the date of this news release and, except as required by applicable law, Vivione does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. Vivione undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of Vivione, or its financial or operating results or (as applicable), their securities.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Disclosure

Please read the terms and conditions section of this website carefully before using the Vivione Biosciences Inc. (the “Company”) web site. By accessing or using this site, you agree to the terms and conditions as set out in the terms and conditions section of this web site. You should review the terms and conditions section regularly as it may change at any time at our sole discretion. If you do not agree to any term or condition, you should not access or otherwise use this site.

General information regarding the Company set forth on the following pages of this website, including management's assessment of the Company's future plans and operations contains forward looking statements that involve substantial known and unknown risks and uncertainties. Wherever possible, words such as "may", ''would", "could", "should", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "aim", "endeavour" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs based on its experience and expertise with respect to future events and are based on information currently available to management. Management uses forward-looking statements because it believes they provide useful information with respect to the Company, and cautions readers that the information may not be appropriate for other purposes and should not be read as guarantees of future performance or results.

Forward looking statements are subject to numerous risks and uncertainties, some of which are beyond the management and the Company’s control, including but not limited to, the impact of general economic conditions, industry conditions, fluctuation of foreign exchange rates, imperfection of estimates, industry competition, availability of qualified personnel and management, stock market volatility, timely and cost effective access to sufficient capital from internal and external sources, ability to integrate and realize anticipated benefits from acquisitions, ability to resell third party network communications at favorable rates, and to effectively manage growth. The Company's actual results, performance or achievement could differ materially from those expressed in or implied by, these forward looking statements and accordingly, no assurance can be given that any of the events anticipated to occur or transpire from the forward looking statements will provide any benefits to the Company. All data presented herein should be read in conjunction with the Company's regulatory filings with the appropriate securities regulatory authorities and the System for Electronic Document Analysis and Retrieval (“SEDAR”). Copies of these filings are available for review under the Company's SEDAR profile at www.sedar.com.